September 10, 2014 by Brad Perriello
Medtronic shares hit a 52-week high today, peaking at $66.21 for the 2nd time in as many days, perhaps buoyed by news of a CE Mark for the latest iteration of its CoreValve replacement heart valve.
Medtronic (NYSE:MDT) shares hit a 52-week high today for the 2nd day in a row, perhaps buoyed by news of a European regulatory approval for 1 of its CoreValve replacement heart valves.
MDT shares peaked yesterday at $65.91 yesterday before subsiding to a $65.54-per-share close. Shares rose to $66.21 today and were trading at $65.99 each as of about 2:30 p.m. Eastern.
